Stock Taper 
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC
Latest 13F filing data - Q3 2023
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 argenx SE | ARGX | 27.43K | $13.48M |
 AtriCure, Inc. | ATRC | 46.26K | $2.03M |
 Illumina, Inc. | ILMN | 80.86K | $11.1M |
 GeneDx Holdings Corp. | WGS | 103.6K | $377.12K |
 Lantheus Holdings, Inc. | LNTH | 142.2K | $9.88M |
 Adicet Bio, Inc. | ACET | 200.2K | $274.27K |
 Pyxis Oncology, Inc. | PYXS | 326.81K | $650.35K |
 10x Genomics, Inc. | TXG | 359.55K | $14.83M |
 SCYNEXIS, Inc. | SCYX | 555.55K | $1.27M |
 Phathom Pharmaceuticals, Inc. | PHAT | 850K | $8.81M |
 Arcus Biosciences, Inc. | RCUS | 869.79K | $15.61M |
 Aura Biosciences, Inc. | AURA | 1.16M | $18.24M |
 Roivant Sciences Ltd. | ROIV | 1.46M | $17.05M |
 Pacific Biosciences of California, Inc. | PACB | 1.46M | $12.22M |
 Zentalis Pharmaceuticals, Inc. | ZNTL | 2.1M | $42.12M |
 Equillium, Inc. | EQ | 4.45M | $3.29M |
 BeyondSpring Inc. | BYSI | 4.96M | $3.97M |